Innovative Prostate Cancer Treatment Introduced In Bangalore, India
High intensity focused ultrasound technology with the Sonablate® 500 medical device now available for patients through HealthCare Global Enterprises Ltd. (HCG)
CHARLOTTE, N.C., August 11, 2010—USHIFU, LLC (“US HIFU”), a worldwide leader in the development, distribution and use of minimally invasive high intensity focused ultrasound (“HIFU”) technologies, and its affiliate India High Intensity Focused Ultrasound Devices Private Limited (“India HIFU”), announce the introduction of Sonablate® HIFU technology for prostate cancer in Bangalore, India at several HealthCare Global Enterprises Ltd. (“HCG”) centers.
Dr. Raghunath S.K., the first urologist in Bangalore to treat prostate cancer using HIFU, treated the city’s first patient today at Bangalore Institute of Oncology, one of the HCG centers to offer Sonablate HIFU.
Sonablate HIFU is a minimally invasive, targeted approach to treating prostate disease with precision-focused ultrasound energy that, when delivered, raises the temperature of the tissue in a matter of seconds. The extreme, rapid-firing heat destroys the tissue at a specific target, known as a lesion, which measures 12x3x3 mm, approximately the size of a grain of rice. Lesions are created throughout the prostate that result in its destruction.
“We are thrilled with this new association with HCG and what it means for prostate cancer patients in India,” said Alex Gonzalez, US HIFU’s vice president of international operations. “Since HCG has 18 cancer care centers across Southeast Asia and India, more men facing prostate cancer will learn about and gain access to the technology through their network.”
Bangalore Institute is the fifth facility in India to offer Sonablate HIFU for men with localized prostate cancer. The first Sonablate HIFU services were introduced in December 2008 in Hyderabad; other cities to subsequently offer the treatment include New Delhi and Mumbai. More than 50 prostate cancer patients have been treated with Sonablate HIFU since its introduction.
“It has been our goal to partner with the finest hospitals in India in order for exponentially more men to gain easier access to the treatment.” said Mukesh Rana, country manager, India HIFU. “We knew there was a need for HIFU in this area because a few Bangalore residents recently traveled more than 2,000 kilometers to New Delhi for treatment.”
# # #
About USHIFU, LLC
USHIFU, LLC (US HIFU), a privately held healthcare company, is a world leader in minimally invasive high intensity focused ultrasound (HIFU) technologies. US HIFU manufactures the Sonablate® 500 medical device and is focused currently on treating primary and recurrent prostate cancer using Sonablate® HIFU. The company is engaged in ongoing research for technological advancements for the Sonablate® system or other ultrasound applications. US HIFU was founded in 2004 and is headquartered in Charlotte, N.C. Additional information can be found at www.ushifu.com.
About India HIFU
India High Intensity Focused Ultrasound Devices Private Limited (India HIFU) is an affiliate of US HIFU. India HIFU sells, markets and services Sonablate® HIFU devices for HIFU treatment of prostate cancer as well as develops new Sonablate® HIFU centers throughout India. Additional information can be found at www.india-hifu.com.
About the Sonablate® 500
The Sonablate® 500 is a minimally invasive medical device that utilizes ultrasound energy to destroy tissue within the body. It was developed by Focus Surgery, Inc. Takai Hospital Supply Ltd. distributes the Sonablate® 500 in Southeast Asia. The Sonablate® 500 is not approved for use in the U.S. The Sonablate® 500 remains investigational in the U.S. and is being studied for the treatment of prostate cancer in clinical trials in the U.S. FDA has made no decision as to the safety or efficacy of the Sonablate® 500 for the treatment of prostate cancer.
Thursday, August 12, 2010
US HIFU - Breaking Barriers in Ultrasound Technology
US HIFU, LLC is a privately held health care company focused on treating primary and recurrent prostate cancer using HIFU, a minimally invasive outpatient procedure which potentially improves patients’ quality of life. US HIFU was founded in 2004 and is headquartered in Charlotte, N.C.
HIFU Around the World
The company is focused on becoming a global market leader utilizing HIFU to revolutionize the delivery of minimally invasive patient care. US HIFU has established partnerships and relationships throughout the world, creating an extensive international presence by making HIFU technology available outside the U.S. in Central America, South America, Canada, India and the Caribbean.
HIFU in the United States
US HIFU is also managing the process of conducting FDA U.S. clinical trials of the Sonablate® 500, including a trial for primary prostate cancer patients and a trial for patients who have experienced radiation failure.
Clinical Trials in US
For more information about clinical trials that are enrolling patients for treating localized prostate cancer with high intensity focused ultrasound, click here.
US HIFU, LLC is a privately held health care company focused on treating primary and recurrent prostate cancer using HIFU, a minimally invasive outpatient procedure which potentially improves patients’ quality of life. US HIFU was founded in 2004 and is headquartered in Charlotte, N.C.
HIFU Around the World
The company is focused on becoming a global market leader utilizing HIFU to revolutionize the delivery of minimally invasive patient care. US HIFU has established partnerships and relationships throughout the world, creating an extensive international presence by making HIFU technology available outside the U.S. in Central America, South America, Canada, India and the Caribbean.
HIFU in the United States
US HIFU is also managing the process of conducting FDA U.S. clinical trials of the Sonablate® 500, including a trial for primary prostate cancer patients and a trial for patients who have experienced radiation failure.
Clinical Trials in US
For more information about clinical trials that are enrolling patients for treating localized prostate cancer with high intensity focused ultrasound, click here.
HIFU DEVICE IN INDIA DECEMBER 2008
USHIFU Announces First Sonablate(R) HIFU Device In India For Minimally Invasive Prostate Cancer Treatment
USHIFU, a worldwide leader in the development, distribution and use of minimally invasive high intensity focused ultrasound technologies, announced the establishment of India HIFU and the launch of Sonablate(R) HIFU services in Hyderabad, India at Dr. Ramayya's Pramila Hospital for the treatment of prostate disease.
Dr. Ramesh Ramayya, President of Urology and Nephrology Services at the hospital said, "The introduction of the Sonablate(R)500 and the HIFU technology for the treatment of prostate cancer marks a major milestone in the practice of urology in the Indian sub-continent."
The Sonablate(R) HIFU will be launched in India officially at an inauguration event held on December 3, 2008 at the Taj Krishna by the Chief Minister Dr. Y.S. Rajashekar Reddy. Additionally, Dr. Madhav Kamat of Jaslok Hospital in Mumbai and Dr. A. Ranganadha Rao, past president of the Urological Society of India will be guests of honor at the inauguration. Dr D. Ramanaidu, film producer, will launch the Prostate Cancer Awareness Program on the same day. The following day, the first HIFU treatments in India will be performed by Dr. Ramayya. USHIFU medical director, Dr. George Suarez will observe the procedure remotely through a virtual private network (VPN) and be able to provide commentary.
"As the population is aging with a healthy lifestyle it is imperative that patients with prostate cancer are offered a viable alternative to the existing therapy options of surgery and radiotherapy. HIFU technology is minimally invasive, far safer than and as effective as existing alternatives. I am sure Sonablate(R) HIFU and India HIFU Centers will be a resounding success in India," continued Dr. Ramayya.
"I have seen HIFU in action and I believe it is a good decision. There are many patients I feel who will benefit with HIFU in India, especially those that do not like surgery. There are also many patients who have had radical prostatectomy or radiotherapy in India; surely there must be some failures, HIFU will be useful in this group too," said Dr. Ganesh Gopalakrishnan, Professor of Urology in CMC, Vellore and President Elect Urological Society of India.
Steve Puckett, Jr., Chief Executive Officer, USHIFU said, "We are extremely enthusiastic about the growth opportunity in the Indian market. Using our unique hybrid medical device-service model we will be able to quickly enter all the major Indian healthcare markets without having to rely on sometimes slow hospital capital spending decisions. We are proud to be able to expeditiously arm Indian physicians with an alternative modality to combat prostate cancer and the significant side effects associate with traditional treatments."
India HIFU is affiliated with USHIFU and International HIFU, the entity through which USHIFU conducts its international business operations and makes the HIFU technologies available to patients at centers outside the United States. India HIFU is the exclusive distributor of the Sonablate(R) system in India, and is responsible for marketing and developing Sonablate(R) HIFU Centers throughout the country
USHIFU, a worldwide leader in the development, distribution and use of minimally invasive high intensity focused ultrasound technologies, announced the establishment of India HIFU and the launch of Sonablate(R) HIFU services in Hyderabad, India at Dr. Ramayya's Pramila Hospital for the treatment of prostate disease.
Dr. Ramesh Ramayya, President of Urology and Nephrology Services at the hospital said, "The introduction of the Sonablate(R)500 and the HIFU technology for the treatment of prostate cancer marks a major milestone in the practice of urology in the Indian sub-continent."
The Sonablate(R) HIFU will be launched in India officially at an inauguration event held on December 3, 2008 at the Taj Krishna by the Chief Minister Dr. Y.S. Rajashekar Reddy. Additionally, Dr. Madhav Kamat of Jaslok Hospital in Mumbai and Dr. A. Ranganadha Rao, past president of the Urological Society of India will be guests of honor at the inauguration. Dr D. Ramanaidu, film producer, will launch the Prostate Cancer Awareness Program on the same day. The following day, the first HIFU treatments in India will be performed by Dr. Ramayya. USHIFU medical director, Dr. George Suarez will observe the procedure remotely through a virtual private network (VPN) and be able to provide commentary.
"As the population is aging with a healthy lifestyle it is imperative that patients with prostate cancer are offered a viable alternative to the existing therapy options of surgery and radiotherapy. HIFU technology is minimally invasive, far safer than and as effective as existing alternatives. I am sure Sonablate(R) HIFU and India HIFU Centers will be a resounding success in India," continued Dr. Ramayya.
"I have seen HIFU in action and I believe it is a good decision. There are many patients I feel who will benefit with HIFU in India, especially those that do not like surgery. There are also many patients who have had radical prostatectomy or radiotherapy in India; surely there must be some failures, HIFU will be useful in this group too," said Dr. Ganesh Gopalakrishnan, Professor of Urology in CMC, Vellore and President Elect Urological Society of India.
Steve Puckett, Jr., Chief Executive Officer, USHIFU said, "We are extremely enthusiastic about the growth opportunity in the Indian market. Using our unique hybrid medical device-service model we will be able to quickly enter all the major Indian healthcare markets without having to rely on sometimes slow hospital capital spending decisions. We are proud to be able to expeditiously arm Indian physicians with an alternative modality to combat prostate cancer and the significant side effects associate with traditional treatments."
India HIFU is affiliated with USHIFU and International HIFU, the entity through which USHIFU conducts its international business operations and makes the HIFU technologies available to patients at centers outside the United States. India HIFU is the exclusive distributor of the Sonablate(R) system in India, and is responsible for marketing and developing Sonablate(R) HIFU Centers throughout the country
Monday, August 9, 2010
NEWS FROM BRUCE
Bruce,
Thank you for this information. I will pass it on to our blog and website. I am so happy all is well. BTW, your brother is also doing great and in addition to being cured with a non detectable PSA after HIFU, he too has had no side effects or complications. Places like John Hopkins are academic centers that typically lag behind the day to day"pulse" of new and disruptive treatments. On the other hand, Dr Mark Schoenberg, chief of urologic oncology at John Hopkins is the Chief Medical Officer for USHIFU. Therefore, there is an obvious connection and a believe in our technology (HIFU) by the John Hopkins department of urology.
Tried and time,,, I am sure HIFU will prevail as the optimal treatment for localized prostate cancer
Regards,
George
George M. Suarez, M.D.
-----Original Message-----
From: Bruce Howard
To: gmsuarezmd@aol.com
Sent: Wed, Aug 4, 2010 1:00 pm
Subject: Fw: Fwd: Enlarged Prostate: Acupuncture for Chronic Prostatitis
My Acupuncturist asked me to send this to you, I'm sure in the hopes that you will recommend him to some of your client's with Prostatitis. He has helped me numerous times over the years with assorted ills. I don't know if you have any faith in Eastern medicine, but I thought I would forward it to you as a favor to him. When I read the suggested treatments for prostate cancer it blows my mind that an institute like Johns Hopkins, so highly regarded, does not even list HIFU as a suggested treatment. Maybe the article was too old. I appreciate what you must go through trying to get your miraculous treatment through the "old school" people in the Medical profession.
I got my psa score back and it was 0.07......thanks again. Continue to have patients contemplating the treatment call me and I will preach the gospel according to George.
Hope all is good with you.
Bruce Howard
Principal
BRUCE HOWARD & ASSOCIATES
Landscape Architects, Site Planners, & Golf Course Designers
4872 S.W. 72nd Avenue
Miami, Florida 33155
(305) 668-3196 Phone
(305) 668-2871 Fax
e-mail: bruce@brucehoward.net
----- Original Message -----
From: Santiago Sifre
To: Bruce Howard
Sent: Wednesday, August 04, 2010 10:26 AM
Subject: Fw: Fwd: Enlarged Prostate: Acupuncture for Chronic Prostatitis
Bruce, maybe you cn send this to your prostate guy and let him know on my behalve that it came from me. I would appreaciate it.
----- Forwarded Message ----
From: Dan Radcliffe
To: Santiago Sifre
Sent: Wed, November 18, 2009 11:44:56 AM
Subject: Fwd: Enlarged Prostate: Acupuncture for Chronic Prostatitis
Begin forwarded message:
From: Johns Hopkins Health Alerts
Date: November 17, 2009 10:02:02 AM EST
To: danradcliffe@mac.com
Subject: Enlarged Prostate: Alternative Treatment for Chronic Prostatitis
Reply-To: editor@johnshopkinshealthalerts.com
Johns Hopkins Health Alerts:
Enlarged Prostate and Prostatitis
Alternative Treatment for Chronic Prostatitis May Help
Should you try acupuncture to relieve the pain of chronic prostatitis? Results from a recent study provide the answer. Read on ...
(800) 829-0422www.johnshopkinshealthalerts.com | Johns Hopkins Health Bookstore | Email this to a friend
Alternative Treatment for Chronic Prostatitis May Help
Should you try acupuncture to relieve the pain of chronic prostatitis? Results from a recent study provide the answer.
Like other forms of chronic pain, chronic prostatitis is a complex condition with no simple solutions. Successful management depends on treating the original source of the pain as well as the neurological and psychosocial problems that often accompany it.
As a result, your doctor may prescribe several different types of medication. Some men also benefit from cognitive behavioral therapy, which can help improve coping strategies and psychological well-being.
But what if you've tried medications and they haven't helped? Should you give acupuncture a try?
Results from a small study in The American Journal of Medicine suggest that acupuncture may provide relief to men with chronic prostatitis. The study compared the potential benefits of acupuncture versus sham (inactive) treatments in 89 men who had symptoms of chronic prostatitis for three or more of the past six months and who had a score of 15 or higher on the National Institutes of Health Chronic Prostatitis Symptom Index.
The men were randomly assigned to receive two acupuncture treatments or two sham treatments a week for 10 weeks. The sham treatments were nearly identical to genuine acupuncture needle insertions except for the location and depth of placement.
True acupuncture was nearly twice as effective as the sham procedure in relieving chronic prostatitis symptoms. Moreover, patients treated with acupuncture were more than twice as likely as the men given the inactive treatment to experience long-term prostatitis relief. Few of the men experienced complete resolution of their symptoms.
This study supports findings from other trials showing a benefit from acupuncture for chronic prostatitis. More study is needed before the treatment can definitively be recommended, but if nothing else has worked for you, a trial of acupuncture might be worth considering.
--------------------------------------------------------------------------------
If you found this health alert interesting and are ready to take the next step, we recommend our authoritative Johns Hopkins Prostate Bulletin. The Johns Hopkins Prostate Bulletin is an indispensable quarterly journal for men with prostate cancer and the other prostate health concerns, including benign prostatic hyperplasia (BPH) and prostatitis. It also deals with side effects and related conditions, such as lower urinary tract symptoms (LUTS), overactive bladder, and erectile dysfunction.
Written by Dr. Jacek L. Mostwin and his esteemed colleagues at the world-renowned James Buchanan Brady Urological Institute, The Johns Hopkins Prostate Bulletin goes beyond the basics to report on the latest therapeutic treatments, advanced news of clinical trials, in-depth reports, new medications, plus detailed answers to subscribers' concerns about all aspects of your prostate health.
Order today at the special web-only discount and you'll receive five FREE Special Reports as INSTANT PDF DOWNLOADS.
For more information, or to order, go to: The Johns Hopkins Prostate Bulletin
Johns Hopkins Publications
Choosing The Right Treatment For Your Prostate Cancer
Choosing the Right Treatment for Your Prostate Cancer is a must-read primer for any man recently diagnosed with prostate cancer who is looking for answers to pressing questions about treatment options. Our specialists explain in-depth:
1.Expectant Management
2.Brachytherapy
3.Radical Prostatectomy
4.External Beam Radiation Therapy
Access the expertise of the specialists at America's #1 Urology Center in this Special Report designed with YOU in mind, to give you the most timely, accurate information on prostate cancer care and treatment.
Look In the Book: Choosing the Right Treatment for Your Prostate Cancer
Read more or order Choosing the Right Treatment for Your Prostate Cancer
Advanced Prostate Cancer Treatments -- Know Your Options When Your Cancer Comes Back
This 113-page guide features discussions with leading experts at Johns Hopkins on specific options for treating advanced prostate cancer to help you sift through all your options to decide the treatment path(s) that are right for YOU. You will learn about current therapies as well as new approaches being developed here at Johns Hopkins and other important medical centers. These treatments include gene therapy to stop the advance of the disease, monoclonal antibodies that zap cancer cells throughout the body, a variety of chemotherapy agents such as Taxotere and angiogenesis inhibitors, drugs that choke off the blood supply to tumors.
Read more or order Advanced Prostate Cancer Treatments
Restoring Sexual Intimacy After Prostate Cancer Treatment
Written by Drs. Jacek Mostwin and H. Ballentine Carter from Hopkins' James Buchanan Brady Urological Institute, Restoring Sexual Intimacy After Prostate Cancer Treatmentpresents the latest thinking on erection rehabilitation after radical prostatectomy. It explore the full range of your erectile dysfunction treatment options -- effective oral medications, injection therapy, penile implants, and more. The report includes answers to dozens of real questions from patients on sexuality and prostate cancer.
Read more or order Restoring Sexual Intimacy After Prostate Cancer Treatment
--------------------------------------------------------------------------------
You are receiving this email as part of your free subscription to Johns Hopkins Health Alerts. Should you wish to unsubscribe, please follow the instructions below. Help us be sure this email Health Alert isn't filtered as spam. Adding our return address johnshopkins to your address book may 'whitelist' us with your filter, helping future Health Alerts get to your inbox.
Did a friend send this to you? Sign up to get your own alert here
Send this email alert to a friend
Unsubscribe from this mailing list
Subscribe to additional health alerts
Update your profile
Need to contact us? Click here: http://www.johnshopkinshealthalerts.com/contact_us/?ET=johnshopkins_blog:e33343:122752a:&st=email
Johns Hopkins Health Alerts
500 Fifth Avenue
19th Floor
New York, NY 10110
Attn: Web Team
We value your privacy and will not rent your email address to anyone. Click here to view our privacy policy.
This information is not intended to substitute for the advice of a physician. Click here for additional information.
Copyright © 2009 MediZine LLC. 500 Fifth Avenue, 19th Floor, New York, NY 10110. All rights reserved.
Johns Hopkins Featured Title:
2009 Prostate Disorders White Paper
This all-in-one comprehensive guide explains everything you need to know about your prostate -- what it is, what it does, and what problems can develop, such as prostatitis, benign prostatic hyperplasia (BPH or enlarged prostate), and prostate cancer. You'll learn key facts about prostate health, discover prostate treatments you never knew existed, and understand what your options are if you're ever diagnosed with prostate cancer. 96 pages.
Read more or order the INSTANT PDF DOWNLOAD EDITION
Read more or order the PRINT EDITION
--------------------------------------------------------------------------------
Come see what's NEWin the
Bookstore
Here you'll find Newsletters, Bulletins, White Papers in both print and instant PDF download formats, plus our latest FREE Special Reports. Johns Hopkins Bookstore
Johns Hopkins has been ranked #1 of America's Best Hospitals by
U.S. News and World Reportfor the 19th consecutive year, ranking #1 in Ear, Nose and Throat, Rheumatology and Urology. For more information, please visit: America's Best Hospital.
Please visit here for more information about Johns Hopkins Patient Services
ReplyReply AllMove...AMERICAN ALBILL McCOLLUMCONTINENTAL ALGLOBALINSURANCEHIFU FOLDERIMPORTANT SAVEDJOSHsavesavedSUAREZGo to Previous message | Go to Next message | Back to Messages Select Message EncodingASCII (ASCII)Greek (ISO-8859-7)Greek (Windows-1253)Latin-10 (ISO-8859-16)Latin-3 (ISO-8859-3)Latin-6 (ISO-8859-10)Latin-7 (ISO-8859-13)Latin-8 (ISO-8859-14)Latin-9 (ISO-8859-15)W. European (850)W. European (CP858)W. European (HPROMAN8)W. European (MACROMAN8)W. European (Windows-1252)Armenia (ARMSCII-8)Baltic Rim (ISO-8859-4)Baltic Rim (WINDOWS-1257)Cyrillic (866)Cyrillic (ISO-8859-5)Cyrillic (KOI8-R)Cyrillic (KOI8-RU)Cyrillic (KOI8-T)Cyrillic (KOI8-U)Cyrillic (WINDOWS-1251)Latin-2 (852)Latin-2 (ISO-8859-2)Latin-2 (WINDOWS-1250)Turkish (ISO-8859-9)Turkish (WINDOWS-1254)Arabic (ISO-8859-6,ASMO-708)Arabic (WINDOWS-1256)Hebrew (856)Hebrew (862)Hebrew (WINDOWS-1255)Chinese Simplified (GB-2312-80)Chinese Simplified (GB18030)Chinese Simplified (HZ-GB-2312)Chinese Simplified (ISO-2022-CN)Chinese Simplified (WINDOWS-936)Chinese Trad.-Hong Kong (BIG5-HKSCS)Chinese Traditional (BIG5)Chinese Traditional (EUC-TW)Japanese (SHIFT_JIS)Japanese (EUC-JP)Japanese (ISO-2022-JP)Korean (ISO-2022-KR)Korean (EUC-KR)Thai (TIS-620-2533)Thai (WINDOWS-874)Vietnamese (TCVN-5712)Vietnamese (VISCII)Vietnamese (WINDOWS-1258)Unicode (UTF-7)Unicode (UTF-8)Unicode (UTF-16)Unicode (UTF-32)| Full Headers Reply Reply All Forward Forward
.
Mail Search
WelcomeInboxNewFoldersMail Options
Copyright 2010 © Yahoo! Inc. Privacy Policy | About Our Ads | Terms of Service | Send Feedback | Help
Thank you for this information. I will pass it on to our blog and website. I am so happy all is well. BTW, your brother is also doing great and in addition to being cured with a non detectable PSA after HIFU, he too has had no side effects or complications. Places like John Hopkins are academic centers that typically lag behind the day to day"pulse" of new and disruptive treatments. On the other hand, Dr Mark Schoenberg, chief of urologic oncology at John Hopkins is the Chief Medical Officer for USHIFU. Therefore, there is an obvious connection and a believe in our technology (HIFU) by the John Hopkins department of urology.
Tried and time,,, I am sure HIFU will prevail as the optimal treatment for localized prostate cancer
Regards,
George
George M. Suarez, M.D.
-----Original Message-----
From: Bruce Howard
To: gmsuarezmd@aol.com
Sent: Wed, Aug 4, 2010 1:00 pm
Subject: Fw: Fwd: Enlarged Prostate: Acupuncture for Chronic Prostatitis
My Acupuncturist asked me to send this to you, I'm sure in the hopes that you will recommend him to some of your client's with Prostatitis. He has helped me numerous times over the years with assorted ills. I don't know if you have any faith in Eastern medicine, but I thought I would forward it to you as a favor to him. When I read the suggested treatments for prostate cancer it blows my mind that an institute like Johns Hopkins, so highly regarded, does not even list HIFU as a suggested treatment. Maybe the article was too old. I appreciate what you must go through trying to get your miraculous treatment through the "old school" people in the Medical profession.
I got my psa score back and it was 0.07......thanks again. Continue to have patients contemplating the treatment call me and I will preach the gospel according to George.
Hope all is good with you.
Bruce Howard
Principal
BRUCE HOWARD & ASSOCIATES
Landscape Architects, Site Planners, & Golf Course Designers
4872 S.W. 72nd Avenue
Miami, Florida 33155
(305) 668-3196 Phone
(305) 668-2871 Fax
e-mail: bruce@brucehoward.net
----- Original Message -----
From: Santiago Sifre
To: Bruce Howard
Sent: Wednesday, August 04, 2010 10:26 AM
Subject: Fw: Fwd: Enlarged Prostate: Acupuncture for Chronic Prostatitis
Bruce, maybe you cn send this to your prostate guy and let him know on my behalve that it came from me. I would appreaciate it.
----- Forwarded Message ----
From: Dan Radcliffe
To: Santiago Sifre
Sent: Wed, November 18, 2009 11:44:56 AM
Subject: Fwd: Enlarged Prostate: Acupuncture for Chronic Prostatitis
Begin forwarded message:
From: Johns Hopkins Health Alerts
Date: November 17, 2009 10:02:02 AM EST
To: danradcliffe@mac.com
Subject: Enlarged Prostate: Alternative Treatment for Chronic Prostatitis
Reply-To: editor@johnshopkinshealthalerts.com
Johns Hopkins Health Alerts:
Enlarged Prostate and Prostatitis
Alternative Treatment for Chronic Prostatitis May Help
Should you try acupuncture to relieve the pain of chronic prostatitis? Results from a recent study provide the answer. Read on ...
(800) 829-0422www.johnshopkinshealthalerts.com | Johns Hopkins Health Bookstore | Email this to a friend
Alternative Treatment for Chronic Prostatitis May Help
Should you try acupuncture to relieve the pain of chronic prostatitis? Results from a recent study provide the answer.
Like other forms of chronic pain, chronic prostatitis is a complex condition with no simple solutions. Successful management depends on treating the original source of the pain as well as the neurological and psychosocial problems that often accompany it.
As a result, your doctor may prescribe several different types of medication. Some men also benefit from cognitive behavioral therapy, which can help improve coping strategies and psychological well-being.
But what if you've tried medications and they haven't helped? Should you give acupuncture a try?
Results from a small study in The American Journal of Medicine suggest that acupuncture may provide relief to men with chronic prostatitis. The study compared the potential benefits of acupuncture versus sham (inactive) treatments in 89 men who had symptoms of chronic prostatitis for three or more of the past six months and who had a score of 15 or higher on the National Institutes of Health Chronic Prostatitis Symptom Index.
The men were randomly assigned to receive two acupuncture treatments or two sham treatments a week for 10 weeks. The sham treatments were nearly identical to genuine acupuncture needle insertions except for the location and depth of placement.
True acupuncture was nearly twice as effective as the sham procedure in relieving chronic prostatitis symptoms. Moreover, patients treated with acupuncture were more than twice as likely as the men given the inactive treatment to experience long-term prostatitis relief. Few of the men experienced complete resolution of their symptoms.
This study supports findings from other trials showing a benefit from acupuncture for chronic prostatitis. More study is needed before the treatment can definitively be recommended, but if nothing else has worked for you, a trial of acupuncture might be worth considering.
--------------------------------------------------------------------------------
If you found this health alert interesting and are ready to take the next step, we recommend our authoritative Johns Hopkins Prostate Bulletin. The Johns Hopkins Prostate Bulletin is an indispensable quarterly journal for men with prostate cancer and the other prostate health concerns, including benign prostatic hyperplasia (BPH) and prostatitis. It also deals with side effects and related conditions, such as lower urinary tract symptoms (LUTS), overactive bladder, and erectile dysfunction.
Written by Dr. Jacek L. Mostwin and his esteemed colleagues at the world-renowned James Buchanan Brady Urological Institute, The Johns Hopkins Prostate Bulletin goes beyond the basics to report on the latest therapeutic treatments, advanced news of clinical trials, in-depth reports, new medications, plus detailed answers to subscribers' concerns about all aspects of your prostate health.
Order today at the special web-only discount and you'll receive five FREE Special Reports as INSTANT PDF DOWNLOADS.
For more information, or to order, go to: The Johns Hopkins Prostate Bulletin
Johns Hopkins Publications
Choosing The Right Treatment For Your Prostate Cancer
Choosing the Right Treatment for Your Prostate Cancer is a must-read primer for any man recently diagnosed with prostate cancer who is looking for answers to pressing questions about treatment options. Our specialists explain in-depth:
1.Expectant Management
2.Brachytherapy
3.Radical Prostatectomy
4.External Beam Radiation Therapy
Access the expertise of the specialists at America's #1 Urology Center in this Special Report designed with YOU in mind, to give you the most timely, accurate information on prostate cancer care and treatment.
Look In the Book: Choosing the Right Treatment for Your Prostate Cancer
Read more or order Choosing the Right Treatment for Your Prostate Cancer
Advanced Prostate Cancer Treatments -- Know Your Options When Your Cancer Comes Back
This 113-page guide features discussions with leading experts at Johns Hopkins on specific options for treating advanced prostate cancer to help you sift through all your options to decide the treatment path(s) that are right for YOU. You will learn about current therapies as well as new approaches being developed here at Johns Hopkins and other important medical centers. These treatments include gene therapy to stop the advance of the disease, monoclonal antibodies that zap cancer cells throughout the body, a variety of chemotherapy agents such as Taxotere and angiogenesis inhibitors, drugs that choke off the blood supply to tumors.
Read more or order Advanced Prostate Cancer Treatments
Restoring Sexual Intimacy After Prostate Cancer Treatment
Written by Drs. Jacek Mostwin and H. Ballentine Carter from Hopkins' James Buchanan Brady Urological Institute, Restoring Sexual Intimacy After Prostate Cancer Treatmentpresents the latest thinking on erection rehabilitation after radical prostatectomy. It explore the full range of your erectile dysfunction treatment options -- effective oral medications, injection therapy, penile implants, and more. The report includes answers to dozens of real questions from patients on sexuality and prostate cancer.
Read more or order Restoring Sexual Intimacy After Prostate Cancer Treatment
--------------------------------------------------------------------------------
You are receiving this email as part of your free subscription to Johns Hopkins Health Alerts. Should you wish to unsubscribe, please follow the instructions below. Help us be sure this email Health Alert isn't filtered as spam. Adding our return address johnshopkins to your address book may 'whitelist' us with your filter, helping future Health Alerts get to your inbox.
Did a friend send this to you? Sign up to get your own alert here
Send this email alert to a friend
Unsubscribe from this mailing list
Subscribe to additional health alerts
Update your profile
Need to contact us? Click here: http://www.johnshopkinshealthalerts.com/contact_us/?ET=johnshopkins_blog:e33343:122752a:&st=email
Johns Hopkins Health Alerts
500 Fifth Avenue
19th Floor
New York, NY 10110
Attn: Web Team
We value your privacy and will not rent your email address to anyone. Click here to view our privacy policy.
This information is not intended to substitute for the advice of a physician. Click here for additional information.
Copyright © 2009 MediZine LLC. 500 Fifth Avenue, 19th Floor, New York, NY 10110. All rights reserved.
Johns Hopkins Featured Title:
2009 Prostate Disorders White Paper
This all-in-one comprehensive guide explains everything you need to know about your prostate -- what it is, what it does, and what problems can develop, such as prostatitis, benign prostatic hyperplasia (BPH or enlarged prostate), and prostate cancer. You'll learn key facts about prostate health, discover prostate treatments you never knew existed, and understand what your options are if you're ever diagnosed with prostate cancer. 96 pages.
Read more or order the INSTANT PDF DOWNLOAD EDITION
Read more or order the PRINT EDITION
--------------------------------------------------------------------------------
Come see what's NEWin the
Bookstore
Here you'll find Newsletters, Bulletins, White Papers in both print and instant PDF download formats, plus our latest FREE Special Reports. Johns Hopkins Bookstore
Johns Hopkins has been ranked #1 of America's Best Hospitals by
U.S. News and World Reportfor the 19th consecutive year, ranking #1 in Ear, Nose and Throat, Rheumatology and Urology. For more information, please visit: America's Best Hospital.
Please visit here for more information about Johns Hopkins Patient Services
ReplyReply AllMove...AMERICAN ALBILL McCOLLUMCONTINENTAL ALGLOBALINSURANCEHIFU FOLDERIMPORTANT SAVEDJOSHsavesavedSUAREZGo to Previous message | Go to Next message | Back to Messages Select Message EncodingASCII (ASCII)Greek (ISO-8859-7)Greek (Windows-1253)Latin-10 (ISO-8859-16)Latin-3 (ISO-8859-3)Latin-6 (ISO-8859-10)Latin-7 (ISO-8859-13)Latin-8 (ISO-8859-14)Latin-9 (ISO-8859-15)W. European (850)W. European (CP858)W. European (HPROMAN8)W. European (MACROMAN8)W. European (Windows-1252)Armenia (ARMSCII-8)Baltic Rim (ISO-8859-4)Baltic Rim (WINDOWS-1257)Cyrillic (866)Cyrillic (ISO-8859-5)Cyrillic (KOI8-R)Cyrillic (KOI8-RU)Cyrillic (KOI8-T)Cyrillic (KOI8-U)Cyrillic (WINDOWS-1251)Latin-2 (852)Latin-2 (ISO-8859-2)Latin-2 (WINDOWS-1250)Turkish (ISO-8859-9)Turkish (WINDOWS-1254)Arabic (ISO-8859-6,ASMO-708)Arabic (WINDOWS-1256)Hebrew (856)Hebrew (862)Hebrew (WINDOWS-1255)Chinese Simplified (GB-2312-80)Chinese Simplified (GB18030)Chinese Simplified (HZ-GB-2312)Chinese Simplified (ISO-2022-CN)Chinese Simplified (WINDOWS-936)Chinese Trad.-Hong Kong (BIG5-HKSCS)Chinese Traditional (BIG5)Chinese Traditional (EUC-TW)Japanese (SHIFT_JIS)Japanese (EUC-JP)Japanese (ISO-2022-JP)Korean (ISO-2022-KR)Korean (EUC-KR)Thai (TIS-620-2533)Thai (WINDOWS-874)Vietnamese (TCVN-5712)Vietnamese (VISCII)Vietnamese (WINDOWS-1258)Unicode (UTF-7)Unicode (UTF-8)Unicode (UTF-16)Unicode (UTF-32)| Full Headers Reply Reply All Forward Forward
.
Mail Search
WelcomeInboxNewFoldersMail Options
Copyright 2010 © Yahoo! Inc. Privacy Policy | About Our Ads | Terms of Service | Send Feedback | Help
Thursday, August 5, 2010
CLICK IN TO MY WEBSITE!
There is new information on Dr. George M. Suarez' website. Make sure that you visit his website:
www.hifumedicalexpert.com - Comments are welcome
www.hifumedicalexpert.com - Comments are welcome
MR guided HIFU
Rapid motion correction in MR-guided high-intensity focused ultrasound heating using real-time ultrasound echo information
Philippe Lourenço de Oliveira, Baudouin Denis de Senneville *, Iulius Dragonu, Chrit T. W. Moonen
Laboratory for Molecular and Functional Imaging: From Physiology to Therapy, UMR 5231 CNRS/Université Bordeaux 2, Bordeaux, France
email: Baudouin Denis de Senneville (baudouin@imf.u-bordeaux2.fr)
*Correspondence to Baudouin Denis de Senneville, UMR 5231, Imagerie Moléculaire et Fonctionnelle, Université Victor Segalen Bordeaux 2, 146, rue Léo Saignat, case 117, 33076 Bordeaux, France.
These two authors contributed equally.
Funded by:
Ligue Nationale Contre le Cancer, Conseil Régional d'Aquitaine: Diagnostic Molecular Imaging EC-FP6-project LSHB-CT-2005-512146
Agence National de la Recherche; project MRgHIFU-ALKT
Philips Healthcare
Philippe Lourenço de Oliveira, Baudouin Denis de Senneville *, Iulius Dragonu, Chrit T. W. Moonen
Laboratory for Molecular and Functional Imaging: From Physiology to Therapy, UMR 5231 CNRS/Université Bordeaux 2, Bordeaux, France
email: Baudouin Denis de Senneville (baudouin@imf.u-bordeaux2.fr)
*Correspondence to Baudouin Denis de Senneville, UMR 5231, Imagerie Moléculaire et Fonctionnelle, Université Victor Segalen Bordeaux 2, 146, rue Léo Saignat, case 117, 33076 Bordeaux, France.
These two authors contributed equally.
Funded by:
Ligue Nationale Contre le Cancer, Conseil Régional d'Aquitaine: Diagnostic Molecular Imaging EC-FP6-project LSHB-CT-2005-512146
Agence National de la Recherche; project MRgHIFU-ALKT
Philips Healthcare
Bojangles on HIFU and ED
people treated with Hifu
by bojangles on Sat Jul 31, 2010 10:09 PM
Quote | Reply Looking for anyone in the late 50's who have had HIFI treatments. Would love to talk to them and see how they're doing. How's your sex life.
You can find me in Cancer Compass
by bojangles on Sat Jul 31, 2010 10:09 PM
Quote | Reply Looking for anyone in the late 50's who have had HIFI treatments. Would love to talk to them and see how they're doing. How's your sex life.
You can find me in Cancer Compass
Subscribe to:
Posts (Atom)